US prescription drug prices rise above inflation
August 27, 2010Sales and Marketing US, prices
A new study of US medicines has found that prices rose 8.3% on average in 2009, well above inflation and …
US court bars stem cell funding
August 26, 2010Sales and Marketing Obama, Stem cells, US
A US district court has temporarily blocked plans to increase government funding of stem cell research in the country. The ruling …
CMC Bio unveils disposable biomanufacturing facility
August 26, 2010Manufacturing and Production CMC Biologics, disposables
Contract manufacturer CMC Biologics has completed the construction of a new manufacturing facility at its site in Bothell near Seattle …
J&J chalks up ninth product recall in 2010
August 26, 2010Manufacturing and Production J&J, JJ
Johnson & Johnson has recalled around 100,000 boxes of its disposable contact lens because of a manufacturing defect, bringing the …
Alcon acquisition makes Novartis eyecare leader
August 26, 2010Sales and Marketing Novartis, ophthalmology
Novartis has finalised its takeover of Alcon that will make it the world’s number one company in ophthalmology. Alcon is …
Janssen to appeal against Velcade decision
August 26, 2010Medical Communications, Sales and Marketing NICE, Thalidomide, Velcade, multiple myeloma
Celgene’s Thalidomide has been recommended by NICE for multiple myeloma ahead of Janssen-Cilag’s Velcade. A final appraisal determination says that …
NICE updates guidance for arthritis treatments
August 26, 2010Sales and Marketing NICE, Roche, rheumatoid arthritis
Five new drugs for rheumatoid arthritis have been given the thumbs up by NICE as second line treatment. Roche’s MabThera, …
Practical Approaches to Early Stage Life Sciences Technology Valuations – Part 2
August 26, 2010Research and Development Kinapse, White paper, life sciences, pharma
With fierce competition in the market for late stage life sciences assets, pharmaceutical companies seeking partnering strategies to bolster pipelines …
Multaq given limited approval from NICE
August 25, 2010Medical Communications, Sales and Marketing Multaq, NICE, Sanofi-Aventis, atrial, dronedarone
NICE has given a restricted approval to Sanofi-Aventis’s Multaq as a second line treatment for atrial fibrillation patients. The guidance …
Avastin patient access scheme too complicated, says NICE
August 25, 2010Sales and Marketing NICE, avastin, patient access
NICE is set to say no again to Avastin for use in patients with colorectal cancer. Avastin was first launched …
Roche signs $1bn peptide deal with Aileron
August 25, 2010Research and Development, Sales and Marketing Aileron, Roche, peptide, stapled peptide therapeutics
Roche has entered an agreement with a US biopharma company Aileron Therapeutics to develop and commercialise drugs called Stapled Peptide …
Sutent disappoints in lung cancer
August 24, 2010Research and Development, Sales and Marketing NSCLC, Pfizer, Sutent, Tarceva
Pfizer’s Sutent has failed to improve overall survival in lung cancer patients when combined with Roche’s Tarceva. Pfizer’s SUN 1087 …
New joiners at Life
August 24, 2010Medical Communications Life, Life healthcare communications, appointment, medical communications
Several new faces have joined the regulars at Life Healthcare Communications – seen here in the Hernes Oak (a pub …
J&J appoints quality tsar to oversee manufacturing revamp
August 24, 2010Manufacturing and Production J&J, JJ, recalls
Johnson & Johnson plans to beef up senior management across its three business units as part of a broader programme …
‘Smart’ vial cap reminds patients to take their medicine
August 24, 2010Manufacturing and Production Med Time, Rexam
UK packaging giant Rexam has thrown its weight behind a ‘smart’ pill vial that reminds patients when to take their …
Avandia letter misleading, FDA tells Glaxo
August 24, 2010Sales and Marketing Avandia, GSK
GlaxoSmithKline’s travails over controversial diabetes drug Avandia show no sign of abating as members of a key regulatory panel accused …
Pharma provides aid for Pakistan
August 24, 2010Sales and Marketing GSK, NGO, Novartis, Pakistan, disaster, pharma, relief
The pharma industry is providing donations to help those affected by the mass flooding across Pakistan. As many as 20 …
Manufacturing news in brief
August 24, 2010Manufacturing and Production AMRI, Genmab, SAFC Pharma, Stirling Pharmaceuticals
UK contract manufacturer Aesica has invested £3 million in a high-containment manufacturing facility at its site in Queenborough, Kent, that …
Encouraging data for Eisai epilepsy drug
August 24, 2010Sales and Marketing Eisai, epilepsy, perampanel, phase III, seizures, study 306
A new phase III study for Eisai’s perampanel (E2007) suggests the first-in-class treatment is effective as an adjunctive treatment of …
GSK shingles vaccine enters late stage trials
August 23, 2010Research and Development, Sales and Marketing GSK, Vaccine, shingles
GlaxoSmithKline has started enrollment for phase III trials for its herpes zoster vaccine for the prevention of shingles. The trials …
Latest content
Brenntag and dsm-firmenich expand biopharma vitamin partnership
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
